Open AccessChoroidal osteoma: the varied response of subretinal fluid to anti-VEGF agents
Author(s) -
Subirang,
Meenakshi Sindhu,
Khushboo Sheoran,
Ravinder Kaur
Publication year - 2020
Publication title -
bmj case reports
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.231
H-Index - 26
ISSN - 1757-790X
DOI - 10.1136/bcr-2020-234357
Subject(s) - medicine , ranibizumab , ophthalmology , vegf receptors , retinal , aflibercept , vascular endothelial growth factor , choroid , serous fluid , retina , pathology , bevacizumab , surgery , chemotherapy , physics , optics
The present case shows a remarkable long-term response of the choroidal neovascular membrane and serous retinal detachment associated with choroidal osteoma to two injections of ranibizumab which is an anti-vascular endothelial growth factor (anti-VEGF) agent.